The largest database of trusted experimental protocols

Psuper retro plasmid

Manufactured by Oligoengine
Sourced in United States

PSUPER.retro plasmid is a lab equipment product designed for molecular biology applications. It functions as a vector for cloning and expressing short hairpin RNA (shRNA) sequences in mammalian cells. The product enables the construction of retroviral shRNA expression systems.

Automatically generated - may contain errors

4 protocols using psuper retro plasmid

1

Silencing GPATCH3 in Human Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Double-strand oligonucleotides corresponding to the target sequences were cloned into the pSuper-Retro plasmid (Oligoengine). The following sequences were targeted for human GPATCH3 mRNA: 1#: 5’-GCAAGCGTGGATTGGGGTA-3’; 2#: 5’-CCTACCTGGCAGATATACC-3’; 3#: 5’-GTGAAGAAATACCCCAAGG-3’. Small interfering RNAs (siRNAs) targeting human GPATCH3 were purchased from Ribobio. 1# siRNA: 5’-GGAACAGAGACTCCGAGAT-3’, 2# siRNA: 5’-GTACCATGGAGAGAAGCTA-3’. siRNA were delivered into A549s and HFFs by PepMute siRNA transfection reagent (SignaGen) according to procedures recommended by the manufacturer.
+ Open protocol
+ Expand
2

ACSL4 knockdown in MDA-MB-231 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MDA-MB-231 cell line was used for stable transfection with pSUPER.retro plasmid (OligoEngine, Seattle, WA, USA) containing shRNA ACSL4 (5′AAGATTATTCTGTGGATGA-3′) or the empty vectors as control in Opti-MEM medium and Lipofectamine 2000 reagent (Invitrogen) as previously described by for our group [5 (link)]. ACSL4 knockdown was evaluated through Western blot (Supplementary Fig. 1B).
+ Open protocol
+ Expand
3

Mitofusin 2 Silencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The specific primers used for real-time PCR were: human Mitofusin 2 cDNA forward, 5′-ATGCATCCCCACTTAAGC -3′ and reverse, 5′-GTTCTTCTGTGGTAACGG -3′; and human We used a murine Mfn2-shRNA which has been already proved in our previous works and reported [10] (link). BLAST data showed that the 19-mer RNAi sequence is specific against the mRNA sequence of human Mfn2 with 100% identity with the Mfn2 transcript of Homo sapiens, without targeting Mfn1, the other isoform that participates in mitochondrial fusion. We also designed a human Mfn2-specific shRNA. We used pSUPER.retro plasmid (OligoEngine, Seattle, WA, USA) containing a 19-bp DNA fragment of the human Mfn2 (GGAAGACATTGAGTTCCAT) named hMfn2-shRNA in the adequate frame shift to generate a shRNA.
+ Open protocol
+ Expand
4

Evaluating Mitochondrial Dynamics in WJ-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to evaluate mitochondrial presence and transport, WJ-MSCs (5 × 10 5 cells/well) were grown up to 50%-70% confluence onto cover glass dishes and mitochondria were labeled with a mitochondrial target sequence linked to a fluorescent dye. Transfection was performed with a reagent mixture including 0.8 μg pSUPER-retro plasmid (Oligoengine,VEC-PRT-0001) containing the mitochondrial target sequence constituted by a cytochrome oxidase subunit and 0.8 μg yellow fluorescence protein mt-YFP (Clontech, 632,443) in Opti-MEM medium (Life Technologies, 31,985-070), adding 2 μl lipofectamine 2000 transfection reagent (Invitrogen, 11,668-019) according to the manufacturer's instructions. Cells were incubated with this mix in DMEM (Life Technologies, 12,800-082) supplemented with 10% v/v fetal bovine serum in PBS without antibiotics for 5 h at 37 °C and 5% CO 2 . Culture medium was then replaced by one supplemented with 10% v/v fetal bovine serum in PBS and antibiotics (100 U/ml penicillin/streptomycin, 0.3 μg/ml gentamicin and 50 μg/ml fungizone) under the same conditions for 48 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!